Status: Recruiting
Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension
HQ-HTN-G01 is a prospective, multicenter, single arm, open label, early feasibility study to evaluate initial safety and device design concept of "HyperQureTM RDN System", laparoscopic renal denervation therapy, in patients with resistant hypertension on three(3) or more antihypertensive medications
Participants needed: 15
Trial details
Age: 22-80Biological sex: AllType: InterventionalSponsor: DeepQure Inc.Updated: Aug 10, 2026Locations: 6
Eligibility criteria
Aged ≥22 and ≤80 years old at time of enrollment (consent). [+4]
Has coverage diameter of renal artery less than 2 mm or greater than 11 mm. [+42]